For a pediatric dengue patient who received an initial crystalloid bolus of 10 cc/kg, the order is to give a total of 7 cc/kg over 2 hours using hydroxyethyl starch (HES) for two‑thirds of the volume and Plasma‑Lyte for one‑third, but only one bag of HES is available; how should the fluid regimen be adjusted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Not Use HES – Switch to Crystalloid Only

Given that only one bag of HES is available and current guidelines strongly recommend against using hydroxyethyl starch (HES) in pediatric patients, you should abandon the HES order entirely and administer the full 7 cc/kg over 2 hours using Plasma-Lyte (or other balanced crystalloid) alone. 1, 2

Why HES Should Not Be Used in Dengue

The 2026 Surviving Sepsis Campaign guidelines carry a strong recommendation against using starches in acute resuscitation of children with septic shock (moderate quality evidence) 1. While dengue shock syndrome has unique pathophysiology, the evidence against HES is compelling:

  • French guidelines (2022) explicitly state: Do not use HES for sepsis/septic shock due to increased mortality and renal replacement therapy requirements 2
  • Dengue-specific research shows harm: Recent studies in Southeast Asian children with dengue shock found that liberal colloid use (>4 hours) was associated with:
    • 8-fold increased risk of respiratory compromise requiring ventilation (OR 8.84, p<0.001) 3
    • Higher costs without meaningful benefit 3
    • More pronounced decline in kidney function 4

The Correct Approach

Immediate action: Give the full 7 cc/kg over 2 hours using Plasma-Lyte alone (or Ringer's Lactate if Plasma-Lyte unavailable).

Rationale for crystalloid-only approach:

  1. Dengue-specific evidence supports crystalloids: A landmark 2005 RCT in Vietnamese children with dengue shock found that Ringer's lactate performed similarly to colloids for moderate shock, with only minor differences in hematocrit recovery time 5

  2. Balanced crystalloids are preferred: The 2026 guidelines suggest balanced/buffered crystalloids over normal saline for pediatric shock 1

  3. Frequent reassessment is key: Guidelines emphasize that hemodynamic status should be reassessed after every fluid bolus, with therapy titrated to clinical markers and discontinued if shock resolves or fluid overload develops 1

Clinical Monitoring During Infusion

Monitor these parameters every 15-30 minutes:

  • Heart rate and blood pressure
  • Capillary refill time
  • Level of consciousness
  • Urine output
  • Signs of fluid overload: pulmonary edema, hepatomegaly, respiratory distress 1

If Shock Persists After Crystalloid

If the patient remains in shock after the 7 cc/kg crystalloid infusion:

  • Give additional 10-20 cc/kg crystalloid boluses (up to 40-60 cc/kg total in first hour if ICU available) 1
  • Consider vasoactive support (epinephrine preferred over dopamine) 6
  • Do NOT reach for the single HES bag – the risks outweigh any theoretical benefit

Critical Pitfall to Avoid

The original order reflects outdated practice patterns. While some centers still use colloids for severe dengue shock based on older WHO guidelines, the evidence has shifted dramatically. The 2025 study of 1,278 Vietnamese children with dengue shock found that a colloid-to-crystalloid ratio >1.6 significantly predicted need for mechanical ventilation 4. Your patient would have received a 2:1 ratio under the original order – precisely the harmful threshold identified in recent research.

Bottom line: The limited HES availability is actually protecting your patient from potential harm. Proceed confidently with crystalloid-only resuscitation and close clinical monitoring.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.